• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Wednesday

    2/8/23 1:45:50 PM ET
    $ALLR
    $ASST
    $ASTI
    $AUID
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology
    Get the next $ALLR alert in real time by email

     

    On Wednesday, 20 companies achieved new lows for the year.

    52-Week Low Highlights:

    • Jack Henry & Associates (NASDAQ:JKHY) was the largest firm by market cap to set a new 52-week low.
    • The smallest company by market cap to set a new 52-week low was Edible Garden (NASDAQ:EDBL).
    • Titan Medical (NASDAQ:TMDI)'s stock dropped the most, trading down 70.69% to reach a new 52-week low.
    • TIM (NYSE:TIMB) was the biggest winner of the bunch, with shares actually trading up 0.19% after it rebounded from its new 52-week low.

    On Wednesday, the following stocks hit new 52-week lows:

    • Jack Henry & Associates (NASDAQ:JKHY) shares set a new 52-week low of $164.00. The stock traded down 9.0%.
    • TIM (NYSE:TIMB) shares set a new 52-week low of $10.48. The stock traded up 0.19%.
    • Lumen Technologies (NYSE:LUMN) stock drifted down 19.04% on Wednesday morning to hit a new 52-week low of $3.90.
    • Freightos (NASDAQ:CRGO) shares set a new 52-week low of $6.50. The stock traded down 6.25%.
    • Semler Scientific (NASDAQ:SMLR) stock hit $21.21 on Wednesday morning, setting a new 52-week low for a change of down 6.73%.
    • Mastech Digital (AMEX:MHH) shares reached a new 52-week low of $10.70 on Wednesday morning, moving down 14.87%.
    • BM Technologies (AMEX:BMTX) shares made a new 52-week low of $4.25 on Wednesday. The stock was down 1.39% for the day.
    • Ascent Solar Technologies (NASDAQ:ASTI) shares set a new 52-week low of $0.89. The stock traded down 15.07%.
    • Asset Entities (NASDAQ:ASST) stock hit $2.29 on Wednesday morning, setting a new 52-week low for a change of down 2.06%.
    • Titan Medical (NASDAQ:TMDI) shares fell to $0.23 on Wednesday, setting a new 52-week low with a shift of down 70.69%.
    • MGO Global (NASDAQ:MGOL) shares were down 4.18% for the day, having made a 52-week low of $2.02.
    • Cadrenal Therapeutics (NASDAQ:CVKD) stock dropped to a yearly low on Wednesday of $2.04. Shares traded down 5.56%.
    • Smart Powerr (NASDAQ:CREG) shares set a new yearly low of $1.80 this morning. The stock was down 2.42% on the session.
    • AuthID (NASDAQ:AUID) shares hit a yearly low of $0.43. The stock was down 4.95% on the session.
    • Revelation Biosciences (NASDAQ:REVB) shares set a new yearly low of $5.79 this morning. The stock was down 8.3% on the session.
    • Tenax Therapeutics (NASDAQ:TENX) shares moved down 10.74% on Wednesday to hit a new 52-week low of $1.31, drifting down 10.74%.
    • Allarity Therapeutics (NASDAQ:ALLR) stock broke to a new 52-week low of $0.19 on Wednesday. Shares of the company traded down 7.11%.
    • SINTX Technologies (NASDAQ:SINT) stock achieved a new 52-week low on Wednesday morning, hitting $3.23 and moving down 43.43%.
    • Edible Garden (NASDAQ:EDBL) stock achieved a new 52-week low on Wednesday morning, hitting $4.25 and moving down 8.33%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $ALLR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALLR
    $ASST
    $ASTI
    $AUID

    CompanyDatePrice TargetRatingAnalyst
    TIM S.A.
    $TIMB
    12/11/2025$24.00Underperform
    BofA Securities
    Jack Henry & Associates Inc.
    $JKHY
    12/8/2025$215.00Mkt Perform → Outperform
    Keefe Bruyette
    Jack Henry & Associates Inc.
    $JKHY
    11/20/2025$198.00Mkt Perform → Strong Buy
    Raymond James
    Jack Henry & Associates Inc.
    $JKHY
    11/6/2025$187.00Neutral → Buy
    Compass Point
    TIM S.A.
    $TIMB
    11/5/2025Sector Outperform → Sector Perform
    Scotiabank
    TIM S.A.
    $TIMB
    11/5/2025$27.00Hold → Buy
    HSBC Securities
    Lumen Technologies Inc.
    $LUMN
    10/31/2025$11.00Buy → Neutral
    Citigroup
    Jack Henry & Associates Inc.
    $JKHY
    10/22/2025$161.00Equal Weight
    Wells Fargo
    More analyst ratings

    $ALLR
    $ASST
    $ASTI
    $AUID
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities resumed coverage on TIM S.A. with a new price target

    BofA Securities resumed coverage of TIM S.A. with a rating of Underperform and set a new price target of $24.00

    12/11/25 3:46:50 PM ET
    $TIMB
    Telecommunications Equipment
    Telecommunications

    Jack Henry upgraded by Keefe Bruyette with a new price target

    Keefe Bruyette upgraded Jack Henry from Mkt Perform to Outperform and set a new price target of $215.00

    12/8/25 8:14:59 AM ET
    $JKHY
    EDP Services
    Technology

    Jack Henry upgraded by Raymond James with a new price target

    Raymond James upgraded Jack Henry from Mkt Perform to Strong Buy and set a new price target of $198.00

    11/20/25 7:57:27 AM ET
    $JKHY
    EDP Services
    Technology

    $ALLR
    $ASST
    $ASTI
    $AUID
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Shaw Steven A bought $29,432 worth of shares (4,073 units at $7.23) (SEC Form 4)

    4 - Mastech Digital, Inc. (0001437226) (Issuer)

    12/11/25 7:47:51 AM ET
    $MHH
    Professional Services
    Consumer Discretionary

    Chief Medical Officer Rich Stuart bought $50,792 worth of shares (5,000 units at $10.16), increasing direct ownership by 90% to 5,266 units (SEC Form 4)

    4 - TENAX THERAPEUTICS, INC. (0000034956) (Issuer)

    12/10/25 6:48:57 PM ET
    $TENX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Investment Officer Honigblum Gregg R. bought $34,896 worth of shares (8,200 units at $4.26), increasing direct ownership by 4% to 201,067 units (SEC Form 4)

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    12/9/25 8:00:05 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    $ALLR
    $ASST
    $ASTI
    $AUID
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Shaw Steven A bought $29,432 worth of shares (4,073 units at $7.23) (SEC Form 4)

    4 - Mastech Digital, Inc. (0001437226) (Issuer)

    12/11/25 7:47:51 AM ET
    $MHH
    Professional Services
    Consumer Discretionary

    Chief Medical Officer Rich Stuart bought $50,792 worth of shares (5,000 units at $10.16), increasing direct ownership by 90% to 5,266 units (SEC Form 4)

    4 - TENAX THERAPEUTICS, INC. (0000034956) (Issuer)

    12/10/25 6:48:57 PM ET
    $TENX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Investment Officer Honigblum Gregg R. bought $34,896 worth of shares (8,200 units at $4.26), increasing direct ownership by 4% to 201,067 units (SEC Form 4)

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    12/9/25 8:00:05 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    $ALLR
    $ASST
    $ASTI
    $AUID
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Edible Garden's Award-Winning Kick. Sports Nutrition Now Available on Target.com

    BELVIDERE, NJ, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (NASDAQ:EDBL, EDBLW), EDBLW), a leading provider of controlled environment agriculture (CEA) solutions and sustainable, locally grown organic produce, today announced that its award-winning Kick. Sports Nutrition product line is now available on Target.com, expanding the brand's digital footprint and strengthening its rapidly growing omnichannel strategy. Kick. Sports Nutrition, Edible Garden's clean-label, performance-driven product line, features whey and plant-based proteins, pre- and post-workout formulations, and hydration-energy blends developed to support athletes and a

    12/11/25 8:30:00 AM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    Cadrenal Therapeutics Acquires VLX-1005, a First-in-Class Phase 2 12-LOX Inhibitor for Patients with Heparin-Induced Thrombocytopenia (HIT)

    Novel first-in-class therapeutic targeting a key immune signaling pathway and the underlying cause of HITIt is the first and only potent, highly selective inhibitor of human 12-LOX in clinical testing, distinguishing it from related compounds.Orphan Drug and Fast Track designations from the FDA PONTE VEDRA, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (NASDAQ:CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today announced the acquisition of VLX-1005 and related 12-lipoxygenase (12-LOX) assets from Veralox Therapeutics ("Veralox"). The acquisition immediately strengthens Cadren

    12/11/25 8:05:00 AM ET
    $CVKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Putnam Greene Financial Corporation Chooses Jack Henry to Improve Operations Across Four Banks

    Bank holding company strengthens operations and digital experiences to better serve growing Georgia communities MONETT, Mo., Dec. 10, 2025 /PRNewswire/ -- Jack Henry™ (NASDAQ:JKHY) announced today that Putnam Greene Financial Corporation, a Georgia-based bank holding company, has selected Jack Henry to modernize its technology infrastructure, standardize operations, and enhance digital experiences across its four subsidiary banks. Founded in 1998, Putnam Greene Financial Corporation operates four independently chartered, community-focused banks: Farmers & Merchants Bank, The F

    12/10/25 8:30:00 AM ET
    $JKHY
    EDP Services
    Technology

    $ALLR
    $ASST
    $ASTI
    $AUID
    SEC Filings

    View All

    SEC Form 425 filed by Semler Scientific Inc.

    425 - Semler Scientific, Inc. (0001554859) (Subject)

    12/12/25 4:07:51 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Semler Scientific Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Other Events, Financial Statements and Exhibits

    8-K - Semler Scientific, Inc. (0001554859) (Filer)

    12/12/25 4:05:41 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form EFFECT filed by SiNtx Technologies Inc.

    EFFECT - Sintx Technologies, Inc. (0001269026) (Filer)

    12/12/25 12:15:20 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    $ALLR
    $ASST
    $ASTI
    $AUID
    Leadership Updates

    Live Leadership Updates

    View All

    Lumen Appoints Jim Fowler as Chief Technology & Product Officer

    Lumen Technologies (NYSE: LUMN) today announced that Jim Fowler has been appointed Executive Vice President and Chief Technology & Product Officer, effective Jan. 5, 2026. Fowler will succeed Dave Ward, who is departing to assume the role of President and Chief Architect at Salesforce, the world's #1 AI CRM. Ward will remain with Lumen through Jan. 23, 2026, to support a smooth transition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205883387/en/Jim Fowler, who will assume the role of Executive Vice President and Chief Technology & Product Officer at Lumen Technologies, effective Jan. 5, 2026. Source: Lumen Technologies Fow

    12/5/25 8:30:00 AM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    Cadrenal Therapeutics Appoints Dr. Lee Golden to Board of Directors

    PONTE VEDRA, Fla., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (NASDAQ:CVKD), a biopharmaceutical company developing transformative therapeutics to overcome current gaps in anticoagulation therapy, today announced the appointment of Lee Scott Golden, M.D., to its Board of Directors, effective immediately. Dr. Golden will serve as an independent director. Dr. Golden currently serves as Executive Vice President and Chief Medical Officer at PTC Therapeutics, Inc. (NASDAQ:PTCT), where he leads global clinical development across a broad rare disease pipeline. Before joining PTC, Dr. Golden served as the Chief Medical Officer at Espero BioPharma, Inc., a development-stage card

    12/1/25 9:00:00 AM ET
    $CVKD
    $PTCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Freightos appoints Michael Netter as CRO to Drive Global Go-to-Market Strategy

    Digital Logistics Expert Brings Proven Logistics Tech Experience to Drive Expansion Across the Freight Ecosystem BARCELONA, Spain, Nov. 10, 2025 /PRNewswire/ -- Freightos Limited (NASDAQ:CRGO), the leading digital freight booking and payment platform for the international freight industry, today announced the appointment of Michael Netter as Chief Revenue Officer (CRO). Netter will lead global revenue strategy, sales excellence and commercial execution. Netter brings deep experience in B2B SaaS, digital logistics, IoT solutions and Go-To-Market leadership. This includes his most recent role as Vice President of Sales EMEA at Proemion, an IoT and Industry 4.0 software company.  Prior to that

    11/10/25 7:00:00 AM ET
    $CRGO
    Integrated Freight & Logistics
    Industrials

    $ALLR
    $ASST
    $ASTI
    $AUID
    Financials

    Live finance-specific insights

    View All

    Cadrenal Therapeutics Acquires VLX-1005, a First-in-Class Phase 2 12-LOX Inhibitor for Patients with Heparin-Induced Thrombocytopenia (HIT)

    Novel first-in-class therapeutic targeting a key immune signaling pathway and the underlying cause of HITIt is the first and only potent, highly selective inhibitor of human 12-LOX in clinical testing, distinguishing it from related compounds.Orphan Drug and Fast Track designations from the FDA PONTE VEDRA, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (NASDAQ:CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the limitations of current anticoagulation therapy, today announced the acquisition of VLX-1005 and related 12-lipoxygenase (12-LOX) assets from Veralox Therapeutics ("Veralox"). The acquisition immediately strengthens Cadren

    12/11/25 8:05:00 AM ET
    $CVKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Strive Announces $500,000,000 SATA At-The-Market Program

    DALLAS, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Strive, Inc. (NASDAQ:ASST, SATA)) ("Strive" or the "Company") today announced that it has entered into a sales agreement pursuant to which Strive may issue and sell shares of its Variable Rate Series A Perpetual Preferred Stock, $0.001 par value per share (the "SATA Stock"), having an aggregate offering price of up to $500,000,000 (the "ATM Program"). Strive intends to use the net proceeds from the ATM Program for general corporate purposes, including, among other things, the acquisition of bitcoin and bitcoin-related products and for working capital, the purchase of income generating assets to grow the Company's business, other capital expenditur

    12/9/25 6:27:45 PM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    QVC Group Announces Semi-Annual Interest Payment and Regular Additional Distribution on 4.0% Senior Exchangeable Debentures Due 2029

    WEST CHESTER, Pa., Nov. 17, 2025 /PRNewswire/ -- QVC Group, Inc. ("QVC Group")  (NASDAQ:QVCGA, QVCGP, OTCQB:QVCGB) today announced the payment of a semi-annual interest payment and Regular Additional Distribution to the holders as of Nov 1, 2025 of the 4.0% Senior Exchangeable Debentures due 2029 (the "Debentures") issued by its wholly-owned subsidiary, Liberty Interactive LLC ("LI LLC"). The semi-annual interest payment amount is $20.00 per $1,000 original principal amount of Debentures (a "Debenture"), and the amount of the Regular Additional Distribution is $0.5824 per $1,000 original principal amount of Debentures.

    11/17/25 4:59:00 PM ET
    $LUMN
    $QVCGA
    $QVCGB
    Telecommunications Equipment
    Telecommunications
    Catalog/Specialty Distribution
    Consumer Discretionary

    $ALLR
    $ASST
    $ASTI
    $AUID
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Semler Scientific Inc.

    SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)

    12/12/24 4:16:00 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G filed by Semler Scientific Inc.

    SC 13G - Semler Scientific, Inc. (0001554859) (Subject)

    11/26/24 12:09:40 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SC 13G/A filed by SiNtx Technologies Inc.

    SC 13G/A - Sintx Technologies, Inc. (0001269026) (Subject)

    11/14/24 7:25:52 PM ET
    $SINT
    Medical/Dental Instruments
    Health Care